197 related articles for article (PubMed ID: 14632256)
1. The genome revolution in vaccine research.
Capecchi B; Serruto D; Adu-Bobie J; Rappuoli R; Pizza M
Curr Issues Mol Biol; 2004 Jan; 6(1):17-27. PubMed ID: 14632256
[TBL] [Abstract][Full Text] [Related]
2. Two years into reverse vaccinology.
Adu-Bobie J; Capecchi B; Serruto D; Rappuoli R; Pizza M
Vaccine; 2003 Jan; 21(7-8):605-10. PubMed ID: 12531326
[TBL] [Abstract][Full Text] [Related]
3. Reverse vaccinology, a genome-based approach to vaccine development.
Rappuoli R
Vaccine; 2001 Mar; 19(17-19):2688-91. PubMed ID: 11257410
[TBL] [Abstract][Full Text] [Related]
4. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.
Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V
J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644
[TBL] [Abstract][Full Text] [Related]
5. Reverse vaccinology: a genome-based approach for vaccine development.
Masignani V; Rappuoli R; Pizza M
Expert Opin Biol Ther; 2002 Dec; 2(8):895-905. PubMed ID: 12517268
[TBL] [Abstract][Full Text] [Related]
6. Genome-based approaches to develop vaccines against bacterial pathogens.
Serruto D; Serino L; Masignani V; Pizza M
Vaccine; 2009 May; 27(25-26):3245-50. PubMed ID: 19200820
[TBL] [Abstract][Full Text] [Related]
7. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.
Serruto D; Bottomley MJ; Ram S; Giuliani MM; Rappuoli R
Vaccine; 2012 May; 30 Suppl 2(0 2):B87-97. PubMed ID: 22607904
[TBL] [Abstract][Full Text] [Related]
8. Reverse vaccinology and vaccines for serogroup B Neisseria meningitidis.
Kelly DF; Rappuoli R
Adv Exp Med Biol; 2005; 568():217-23. PubMed ID: 16107075
[TBL] [Abstract][Full Text] [Related]
9. Developing vaccines in the era of genomics: a decade of reverse vaccinology.
Seib KL; Zhao X; Rappuoli R
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709
[TBL] [Abstract][Full Text] [Related]
10. Application of Reverse Vaccinology and Immunoinformatic Strategies for the Identification of Vaccine Candidates Against Shigella flexneri.
Leow CY; Chuah C; Abdul Majeed AB; Mohd Nor N; Leow CH
Methods Mol Biol; 2022; 2414():17-35. PubMed ID: 34784029
[TBL] [Abstract][Full Text] [Related]
11. Rational antibacterial vaccine design through genomic technologies.
Grandi G
Int J Parasitol; 2003 May; 33(5-6):615-20. PubMed ID: 12782059
[TBL] [Abstract][Full Text] [Related]
12. Antigen identification starting from the genome: a "Reverse Vaccinology" approach applied to MenB.
Palumbo E; Fiaschi L; Brunelli B; Marchi S; Savino S; Pizza M
Methods Mol Biol; 2012; 799():361-403. PubMed ID: 21993656
[TBL] [Abstract][Full Text] [Related]
13. Computer Aided Reverse Vaccinology: A Game-changer Approach for Vaccine Development.
Srivastava P; Jain CK
Comb Chem High Throughput Screen; 2023; 26(10):1813-1821. PubMed ID: 36200250
[TBL] [Abstract][Full Text] [Related]
14. ReVac: a reverse vaccinology computational pipeline for prioritization of prokaryotic protein vaccine candidates.
D'Mello A; Ahearn CP; Murphy TF; Tettelin H
BMC Genomics; 2019 Dec; 20(1):981. PubMed ID: 31842745
[TBL] [Abstract][Full Text] [Related]
15. Selection of Vaccine Candidates for Fish Pasteurellosis Using Reverse Vaccinology and an In Vitro Screening Approach.
Andreoni F; Amagliani G; Magnani M
Methods Mol Biol; 2016; 1404():181-192. PubMed ID: 27076298
[TBL] [Abstract][Full Text] [Related]
16. The promise of reverse vaccinology.
Heinson AI; Woelk CH; Newell ML
Int Health; 2015 Mar; 7(2):85-9. PubMed ID: 25733557
[TBL] [Abstract][Full Text] [Related]
17. The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology.
Masignani V; Pizza M; Moxon ER
Front Immunol; 2019; 10():751. PubMed ID: 31040844
[TBL] [Abstract][Full Text] [Related]
18. Reverse vaccinology.
Rappuoli R
Curr Opin Microbiol; 2000 Oct; 3(5):445-50. PubMed ID: 11050440
[TBL] [Abstract][Full Text] [Related]
19. Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design.
Di Salvatore V; Russo G; Pappalardo F
Methods Mol Biol; 2023; 2673():401-410. PubMed ID: 37258929
[TBL] [Abstract][Full Text] [Related]
20. VacSol: a high throughput in silico pipeline to predict potential therapeutic targets in prokaryotic pathogens using subtractive reverse vaccinology.
Rizwan M; Naz A; Ahmad J; Naz K; Obaid A; Parveen T; Ahsan M; Ali A
BMC Bioinformatics; 2017 Feb; 18(1):106. PubMed ID: 28193166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
